佛慈制药(002644) - 2022 Q1 - 季度财报

Revenue and Profit - The company's revenue for Q1 2022 was CNY 236,878,872.61, representing a 33.50% increase compared to CNY 177,434,087.22 in the same period last year[3] - Net profit attributable to shareholders decreased by 6.96% to CNY 21,496,460.61 from CNY 23,105,239.34 year-on-year[3] - The net profit after deducting non-recurring gains and losses increased by 109.05% to CNY 17,962,206.37 from CNY 8,592,162.90 in the previous year[3] - The total operating revenue for the first quarter of 2022 was CNY 236,878,872.61, an increase of 33.5% compared to CNY 177,434,087.22 in the same period last year[19] - The net profit for the first quarter of 2022 was CNY 25,587,241.97, compared to CNY 27,684,763.31 in the previous year, indicating a decrease of 7.6%[19] - The net profit for the first quarter of 2022 was CNY 21,545,308.08, compared to CNY 23,102,526.78 in the same period last year, indicating a decrease of about 6.8%[20] - The basic earnings per share for the first quarter of 2022 was CNY 0.0421, down from CNY 0.0452 in the previous year, reflecting a decline of approximately 6.9%[20] Expenses and Costs - The total operating costs for the first quarter of 2022 were CNY 211,498,791.15, up from CNY 166,792,293.37, reflecting a year-over-year increase of 26.7%[19] - Research and development expenses rose by 33.17% to CNY 4,024,334.17, reflecting increased investment in R&D[7] - Research and development expenses for the first quarter were CNY 4,024,334.17, up from CNY 3,021,963.41, reflecting a year-over-year increase of 33.3%[19] Cash Flow and Liquidity - Cash flow from operating activities decreased by 9.27% to CNY 26,757,794.43 compared to CNY 29,491,155.97 in the previous year[3] - The net cash flow from operating activities for the first quarter was CNY 26,757,794.43, a decrease from CNY 29,491,155.97 year-over-year, showing a decline of about 9.3%[22] - The net increase in cash and cash equivalents was CNY -38,102,024.81, a 303.14% increase in the negative cash flow compared to CNY -9,451,340.96 in the same period last year[9] - The company's cash and cash equivalents at the end of the first quarter were CNY 385,179,076.46, up from CNY 374,940,257.22 at the beginning of the year, representing an increase of 2.9%[15] - The cash and cash equivalents at the end of the first quarter of 2022 were CNY 384,067,722.30, slightly up from CNY 381,859,384.39 at the end of the previous year[23] - The company reported cash outflows from investing activities of CNY 1,395,928.90, significantly lower than CNY 47,477,850.67 in the previous year, indicating a reduction in investment spending[23] - The cash flow from financing activities showed a net outflow of CNY 14,212,733.33, compared to a net outflow of CNY 20,315,380.81 in the same period last year, reflecting an improvement in financing activities[23] - The company received CNY 3,099,949.30 from financing activities, which is a new cash inflow compared to the previous year[23] Assets and Liabilities - The total assets at the end of the reporting period were CNY 2,455,175,764.25, a 1.47% increase from CNY 2,419,600,456.04 at the end of the previous year[3] - The total assets of the company amounted to CNY 2,455,175,764.25, up from CNY 2,352,093,709.48, indicating a growth of 4.4%[16] - The total liabilities increased to CNY 811,436,051.30 from CNY 724,592,734.61, which is an increase of 12.0%[17] - The company's equity attributable to shareholders was CNY 1,630,766,952.98, compared to CNY 1,614,577,062.37, showing a slight increase of 1.0%[17] Other Information - The company experienced a 55.11% increase in accounts payable, amounting to CNY 290,512,162.90, due to increased procurement of production materials[6] - Accounts receivable increased to CNY 290,232,072.06 from CNY 253,945,827.17, marking a rise of 14.3%[15] - Inventory at the end of the first quarter was CNY 291,715,092.62, compared to CNY 258,831,694.16 at the beginning of the year, reflecting an increase of 12.7%[15] - The company did not receive government tax incentive funds in the current period, leading to a 75.89% decrease in other income to CNY 4,109,801.11 from CNY 17,042,969.46[7] - The first quarter report was not audited, which may affect the reliability of the financial data presented[24] - The company did not report any new product launches or technological advancements during this quarter[24]